Obesity Drugs Considered First-Line Option for Cardiovascular Risk. Anderer S. JAMA 2025 Jul 11. doi: 10.1001/jama.2025.10324.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Anderer S. Obesity Drugs Considered First-Line Option for Cardiovascular Risk. JAMA 2025 Jul 11. doi: 10.1001/jama.2025.10324.
PMID: 40643905